Merck & Co Inc
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to fund its proposed acquisition of cancer drugmaker Seagen, for what would be its largest takeover since 2009, according to […]
Read More
GOP law cut Big Pharma tax rates by 40%, Senate report says
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO of Merck & Co. Inc., […]
Read More
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product. The biotech company generated first-quarter sales of $1.9 billion, […]
Read More
Stocks making the biggest moves premarket: Meta, Teladoc, Harley-Davidson, Southwest Airlines and more
Harley-Davidson motorcycles are displayed for sale at the Cowboy Harley-Davidson dealership on February 02, 2023 in Austin, Texas. Brandon Bell | Getty Images Check out the companies making headlines before the bell: Meta Platforms – Shares jumped 12% after the Facebook parent surpassed Wall Street’s expectations on the top and bottom lines and issued optimistic […]
Read More
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021. NurPhoto | NurPhoto | Getty Images Merck on Thursday reported first-quarter revenue that fell 9% from the same period a year ago largely due to a steep drop in sales […]
Read More
Moderna shares fall despite promising data from cancer vaccine trial
Sopa Images | Lightrocket | Getty Images Shares of Moderna fell Monday as Wall Street chewed over new trial results on the personalized cancer vaccine it is developing with Merck. Merck’s shares were relatively flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, cut the risk of recurrence of skin cancer melanoma […]
Read More
Stocks making the biggest moves premarket: Charles Schwab, Dell, Alphabet, HP Inc. & more
In this article RXDX MRK SCHW GOOG GOOGL MTB WOLF STT MRNA BABA OLLI HPQ BABA PDD JD 9618-HK DELL FOX FOXA LITE Follow your favorite stocksCREATE FREE ACCOUNT Enrique Lores, CEO, HP Scott Mlyn | CNBC Check out the companies making headlines before the bell Monday. Charles Schwab — Shares of Charles Schwab gained […]
Read More
Moderna cancer vaccine with Merck’s Keytruda delays return of deadly skin most cancers
Moderna’s sign is observed outdoors of their headquarters in Cambridge, MA on March 11, 2021. Boston World | Getty Photographs An experimental mRNA vaccine developed by Moderna combined with Merck’s blockbuster immunotherapy Keytruda reduce the possibility of death or recurrence of the most deadly skin cancer by 44% in comparison Keytruda on your own, U.S. […]
Read More
Stocks making the biggest premarket moves: Delta, First Solar, Steve Madden & more
In this article NVO MRK FSLR DAL SHOO Follow your favorite stocksCREATE FREE ACCOUNT Los Angeles, CA – March 29: Delta Air Lines unveils a new $1.9-billion Terminal 3 at Los Angeles International Airport on Tuesday, March 29, 2022 in Los Angeles, CA. Irfan Khan | Los Angeles Times | Getty Images Check out the […]
Read More